4/A: Balchem Corp Director Matthew Wineinger Amends Form 4 to Correct Stock Vesting Period

Matthew Wineinger, a director at Balchem Corp, filed an amended Form 4 to correct the vesting period of restricted stock from three years to one year.

Summary

• Matthew Wineinger, a director of Balchem Corp, filed an amended Form 4 with the SEC.
• The amendment corrects an error in the original Form 4 filed on February 14, 2025.
• The original filing incorrectly stated the vesting period for restricted stock as three years.
• The corrected filing clarifies that the restricted stock vests one year following the grant date.
• On February 12, 2025, Wineinger acquired 980 shares of common stock.
• Following the transaction, Wineinger directly owns 7,142 shares of Balchem Corp.
• The restricted stock is subject to transfer restrictions as per the Restricted Stock Grant Agreement.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing correcting a minor error, indicating a neutral to slightly positive sentiment as it demonstrates attention to detail and compliance.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, ensuring transparency in the market.

Stakeholder Impact

• The correction of the vesting period provides clarity to shareholders regarding the terms of executive compensation.

Key Dates

Keywords

Form 4, Balchem Corp, Matthew Wineinger, restricted stock, vesting period, amendment, BCPC, director